Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA:688266)
China
· Delayed Price · Currency is CNY 109.10
+0.70 (0.65%)
Apr 3, 2025, 2:45 PM CST
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 28.69 billion as of April 3, 2025. Its market cap has increased by 131.87% in one year.
Market Cap
28.69B
Enterprise Value
27.41B
Revenue
533.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
109.10
Market Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 28.69B, an increase of 60.29%. That is a compound annual growth rate of 9.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 28.24B | 71.24% |
| Dec 31, 2024 | 16.49B | 17.70% |
| Dec 29, 2023 | 14.01B | 40.02% |
| Dec 30, 2022 | 10.01B | -29.08% |
| Dec 31, 2021 | 14.11B | -9.10% |
| Dec 31, 2020 | 15.53B | -13.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 312.84B |
| Shenzhen Mindray Bio-Medical Electronics | 283.00B |
| WuXi AppTec | 193.37B |
| Aier Eye Hospital Group | 123.47B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.02B |
| Yunnan Baiyao Group Co.,Ltd | 101.35B |
| Shanghai United Imaging Healthcare | 99.90B |
| Sichuan Biokin Pharmaceutical | 93.16B |